Ronald Kirk Huntsman - 20 Jun 2023 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chief Executive Officer, Director
Signature
/s/ Brad Amman as attorney-in-fact for R. Kirk Huntsman
Issuer symbol
VVOS
Transactions as of
20 Jun 2023
Net transactions value
+$7,420
Form type
4
Filing time
20 Jun 2023, 21:58:39 UTC
Previous filing
20 Jun 2023
Next filing
28 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VVOS Common Stock Purchase $7,420 +14,000 +19% $0.5300 86,521 20 Jun 2023 Direct
holding VVOS Common Stock 1,740,000 20 Jun 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.